Next Quarterly Earnings
Monday, March 29, 2027
Expected
Aktis Oncology is a US-based biotechnology company specializing in the development of innovative radiopharmaceuticals. By leveraging targeted alpha therapies, Aktis Oncology combats cancer with precision and transforms modern oncology to provide improved care and outcomes for patients worldwide.
Aktis Oncology last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -0.44 USD.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.